Skip to main content
4DMEDICAL LIMITED logo

4DMEDICAL LIMITED — Investor Relations & Filings

Ticker · 4DX ISIN · AU0000095416 LEI · 9845000A8F12A6A6FD75 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 546 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country AU Australia
Listing ASX 4DX

About 4DMEDICAL LIMITED

https://4dmedical.com/

4DMedical Limited develops non-invasive respiratory imaging solutions centered on its proprietary XV Technology. This platform utilizes advanced algorithms to transform standard X-ray sequences into four-dimensional quantitative data, visualizing regional lung function in motion. The flagship XV Lung Ventilation Analysis Software (XV LVAS) provides clinicians with detailed maps of airflow distribution throughout the respiratory cycle, facilitating the early detection and monitoring of chronic conditions such as COPD, asthma, and interstitial lung disease. By providing objective, high-resolution insights into lung ventilation without the limitations of traditional pulmonary function tests, the company's cloud-based diagnostic tools aim to improve clinical workflows and patient management. The integration of artificial intelligence further enhances its capability to deliver precise, automated lung tissue analysis.

Recent filings

Filing Released Lang Actions
4DMedical targets US$2.5B PE market entry for CTVQ 3 pages 241.6KB
Regulatory Filings Classification · 68% confidence The document is an ASX announcement by 4DMedical detailing the launch of a clinical evidence program (CLEAR), strategic partnerships, market opportunity, and an investor webinar. It is a corporate press release, not a financial report, dividend notice, management change, or detailed investor presentation. It does not present actual financial results or substantive data. This is a general regulatory announcement on the ASX, serving as a fallback category.
2026-06-02 English
Proposed issue of securities - 4DX 5 pages 17.4KB
Share Issue/Capital Change Classification · 92% confidence The document is an ASX Appendix 3B notice detailing a proposed placement of new securities (options) by 4DMedical Limited, including issue dates, conditions, and terms. This constitutes an announcement of a share issue/capital change rather than a full financial report or regulatory certification. Therefore, it fits the “Share Issue/Capital Change” category (SHA).
2026-06-01 English
Proposed issue of securities - 4DX 5 pages 17.5KB
Share Issue/Capital Change Classification · 92% confidence The document is an ASX Listing Rule Appendix 3B announcement detailing a proposed placement of 56,235 new ordinary shares by 4DMEDICAL LIMITED, including issue price, currency, timetable, and listing rule compliance. This is a share issue/capital change notice.
2026-06-01 English
4DMedical creates EU platform via contextflow acquisition 6 pages 306.2KB
M&A Activity Classification · 90% confidence The document is an ASX announcement by 4DMedical detailing the binding agreement to acquire contextflow GmbH, including purchase price, share and option consideration, transaction terms and milestones. It is clearly an acquisition transaction announcement (merger & acquisition activity), not a financial report, earnings release, board change, or dividend notice. Therefore it should be classified as M&A Activity (Code: TAR).
2026-06-01 English
Application for quotation of securities - 4DX 7 pages 21.2KB
Share Issue/Capital Change Classification · 90% confidence The document is an ASX Appendix 2A ‘Application for quotation of securities’ detailing the issue and quotation of ordinary shares following the exercise of options. It is announcing a capital change (new share issues) and matches the definition of Share Issue/Capital Change (SHA).
2026-05-28 English
CTVQ enters US Outpatient Market via SimonMed 170 sites 3 pages 263.2KB
Regulatory Filings Classification · 88% confidence The document is an ASX announcement detailing a new commercial contract for 4DMedical’s CT:VQ™ product with SimonMed. It does not contain financial results, management or board changes, share issues, dividends, or similar report content. It is a regulatory announcement to the ASX regarding a business development. This fits the catch-all “Regulatory Filings” category for ASX news releases that do not belong to more specific report types.
2026-05-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.